0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Updates |

Update in Women's Health

Carolyn Crandall, MD, MS; and Janet P. Pregler, MD
[+] Article and Author Information

From the Iris Cantor-UCLA Women's Health Center, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, California.


Acknowledgments: The authors thank their colleagues at the David Geffen School of Medicine for their assistance in preparing this article.

Potential Financial Conflicts of Interests: None disclosed.

Requests for Single Reprints: Janet P. Pregler, MD, Iris Cantor-UCLA Women's Health Center, David Geffen School of Medicine at UCLA, 100 UCLA Medical Plaza, Suite 250, Los Angeles, CA 90077; e-mail, japregler@mednet.ucla.edu.

Current Author Addresses: Drs. Crandall and Pregler: Iris Cantor-UCLA Women's Health Center, David Geffen School of Medicine at UCLA, 100 UCLA Medical Plaza, Suite 250, Los Angeles, CA 90077.


Ann Intern Med. 2005;143(11):823-829. doi:10.7326/0003-4819-143-11-200512060-00011
Text Size: A A A

This Update in Women's Health reviews the past year's research publications that have the most relevance to the practice of internal medicine. We have included a summary of new guideline recommendations for the prevention of heart disease in women. Our selection process was guided by advice from our colleagues in general internal medicine, geriatrics, obstetrics and gynecology, cardiology, and oncology.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Cardiovascular Disease Prevention for Women
Posted on February 17, 2006
Nancy Hsueh Beggs
UMDNJ-Robert Wood Johnson Medical School
Conflict of Interest: None Declared

TO THE EDITOR:

In your recent issue, Crandler and Pregler, Update in Women's Health, recognize the American Heart Association Guidelines for Cardiovascular Disease Prevention in Women. Cardiovascular disease (CVD) has been identified as the number one killer of women in the United States and in most developed areas of the world. In the United States alone, more than one-half million women die of CVD each year, exceeding the number of deaths in men and the next 7 causes of death in women combined, disproportionately afflicting racial and ethnic minorities.

Recently the American Heart Association's published 5-point acronym for remembering the guidelines is "ALOHA." A"”Assess your risk and rank yourself as high, intermediate, or lower risk. L"”Lifestyle recommendations are priority No. 1 in heart disease prevention. O"”Other interventions are prioritized according to the expert panel rating scale. H"”Highest priority for therapy is for women at highest risk. A"”Avoid medical therapies called Class III.

I propose a new acronym as a pedagogical tool to better codify the guidelines in practitioners minds. I suggest "DRESS", tying the guidelines into the American Heart Association's national "Go Red-- Red Dress" campaign.

D-Discuss risk assessment: (Assess and stratify risk according to Framingham data and individual risk factors) R-Reinforce lifestyle interventions: (Smoking cessation, exercise, weight management, "heart-healthy" diet) E-Evaluate major risk factors: (Evaluate hypertension, hyperlipidemia, and diabetes and attain treatment goals according to recommended guidelines) S-Start helpful medications (Initiate evidence based pharmacology in high risk patients) S-Stop harmful medications (Avoid Class III harmful interventions such as menopausal hormone therapy, antioxidant, and aspirin in low risk patients)

I hope clinicians find this acronym helpful to implement these new guidelines to prevent cardiovascular death in women.

Nancy Hsueh Beggs, MD, FACP, Associate Professor of Medicine, UMDNJ/Robert Wood Johnson Medical School

Conflict of Interest:

None declared

Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)